Tingting Liu | Atherosclerosis | Innovative Research Award

Innovative Research Award

Tingting Liu
Affiliation Hunan University of Chinese Medicine
Country China
Documents 6
Subject Area Atherosclerosis
Event Medical Lab Scientist Awards
ORCID 0009-0004-1547-5866

Tingting Liu is a researcher affiliated with Hunan University of Chinese Medicine in China whose stated research subject area is atherosclerosis. The research profile is associated with the ORCID identifier 0009-0004-1547-5866. This academic recognition page presents the researcher’s institutional affiliation, subject area, research profile information, and relevant scholarly resources in a structured format.[1]

Abstract

Tingting Liu is affiliated with Hunan University of Chinese Medicine, China, and is identified with the research subject area of atherosclerosis. The profile is linked to an ORCID record that provides a persistent identifier for the researcher and supports the association of scholarly activities with the appropriate researcher identity.This page provides a structured academic overview of the available researcher information in relation to the Innovative Research Award and the Medical Lab Scientist Awards.[1]

Keywords

Tingting Liu, Hunan University of Chinese Medicine, China, atherosclerosis, cardiovascular research, vascular biology, biomedical research, medical laboratory science, research recognition, Innovative Research Award, Medical Lab Scientist Awards, ORCID clinical research, cardiovascular disease research,and translational medicine..[2]

Introduction

Atherosclerosis is a chronic vascular condition involving pathological changes in arterial walls and is an important area of investigation within cardiovascular and biomedical research. Research in this field may involve molecular mechanisms, cellular responses, biomarkers, vascular biology, experimental models, and diagnostic approaches.[2]

Research Profile

Tingting Liu is a researcher at Hunan University of Chinese Medicine, China, whose research focuses on atherosclerosis. The available profile identifies Tingting Liu as a researcher at Hunan University of Chinese Medicine, China, with a research subject area in atherosclerosis. The ORCID record provides a persistent digital identifier that can be used to distinguish the researcher from other scholars with similar names and to connect relevant research outputs where those records have been registered.[3]

Research Contributions

The stated research subject of atherosclerosis places the profile within a multidisciplinary area connecting vascular biology, cardiovascular science, molecular research, laboratory investigation, and clinical research. Research contributions in this domain may address mechanisms underlying vascular disease, biological markers, cellular and molecular pathways, experimental investigation, and approaches to understanding disease progression.[3]

Publications

No specific publication titles, journal records, DOI identifiers, or bibliographic details for Tingting Liu were supplied with the profile information used for this page. Consequently, individual publications are not listed here to avoid attributing articles to a researcher without sufficient bibliographic verification.[4]

Research Impact

Research impact can be documented through several forms of evidence, including peer-reviewed publications, citations, scholarly collaborations, research outputs, and contributions to the scientific literature. Citation-based indicators such as citation counts and h-index values should be interpreted in relation to the database used, disciplinary norms, publication period, and date of measurement..[4]

Award Suitability

The Innovative Research Award profile is associated with Tingting Liu based on the supplied institutional affiliation and research subject area. The identified subject area, atherosclerosis, represents an established field of biomedical and cardiovascular research and can be relevant to research-oriented recognition programs concerned with scientific investigation and laboratory-related disciplines..[5]

Conclusion

Tingting Liu is affiliated with Hunan University of Chinese Medicine in China and is identified with a research focus in atherosclerosis. The researcher is associated with ORCID identifier 0009-0004-1547-5866, which provides a persistent mechanism for researcher identification and scholarly record linkage.The available information supports a concise academic recognition profile while leaving publication and bibliometric details open for verification through authoritative scholarly databases..[5]

References

    1. ORCID. (n.d.). ORCID record: Tingting Liu, ORCID iD 0009-0004-1547-5866. ORCID.
      https://orcid.org/0009-0004-1547-5866
    2. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards.
      https://medicallabscientist.com/
    3. Liu, T., Luo, Q., Yang, S., Yang, D., Lv, X., Zhao, L., & Tuo, Q. (2026). INO80E suppresses oxidized LDL-induced endothelial apoptosis through HDAC1-mediated stabilization of YY1. Biomolecules, 16(8), 1174.
      https://doi.org/10.3390/biom16081174
    4. Sun, T., Luo, Q., Liu, T., Lv, X., Lin, L., Liao, D., Tuo, Q., & Chen, W. (2026). Rosmarinic acid targets AKR1B1 to ameliorate atherosclerosis via vascular endothelial cell energy metabolism regulation. Biomolecules, 16(3), 403.
      https://doi.org/10.3390/biom16030403
    5. Liu, T.-T., Wang, Q., Zhou, Y., Ye, B., Liu, T., Yan, L., Fan, J., Xu, J., Zhou, Y., Xia, Z., & Deng, X. (2024). Discovery of a meisoindigo-derived PROTAC as the ATM degrader: Revolutionizing colorectal cancer therapy via synthetic lethality with ATR inhibitors. Journal of Medicinal Chemistry, 67(9), 7620–7634.
      https://doi.org/10.1021/acs.jmedchem.4c00454